Advisory Research Inc Biomarin Pharmaceutical Inc Transaction History

Advisory Research Inc

  • $512 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $197,139 - $359,415
-2,743 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $218,205 - $340,735
2,743 New
2,743 $338,000
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $202,585 - $237,279
-2,406 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $192,816 - $255,204
2,406 New
2,406 $205,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Advisory Research Inc Portfolio

Follow Advisory Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email